Scientists Have Found Climate-Resistant Coral Reefs Around the World Totaling the Size of Wisconsin



A sophisticated AI-powered examination of coral reef resistance extrapolated into the future found that there’re about 64,000 square miles of coral reefs on Earth that could still be resisting climate change by 2050.

The common theory states that CO2 emissions create a greenhouse effect which warms the seas which causes coral reefs to bleach or even die, yet there are environments—as GNN has frequently reported—where corals seem to be more resilient.


The authors of this new study found that when they used 45,000 observations of coral reefs going back as far as 1960 as the data set for an AI model to examine, it predicted according to 46 different criteria that 25 years from now there’d still be swaths of coal reefs totaling the size of Wisconsin located primarily in 8 countries, and that these would be capable of surviving and thriving in the warming seas.

The findings were presented at Our Ocean Conference in Mombasa, Kenya, and are available on the preprint server EcoEvoRxiv.

Most of the coral distribution was plotted out in the Philippines, Indonesia, Cuba, the Bahamas, and Australia. Belize, Nicaragua, and the Turks and Caicos Islands also showed coral resilience in 2050 according to the estimates.

The criteria for where in the world the AI would map as good coral habitat comes from a concept of ‘coral refuges’ which are observations that coral species can either endure warming seas, recover from damage faster, or avoid damage altogether in certain places.

Where these are in the world comes from the 45,000 observations mentioned earlier.

Why coral seem to enjoy these conditions in these particular places isn’t exactly clear—particularly as regards Nicaragua’s neighbor Honduras, where the country’s largest coral reef is also the victim of substantial ecosystem disturbance by human activity, yet seems to be flourish year round.

Sara Hashemi, a daily correspondent at Smithsonian Magazine, wrote that the authors of the new study want their work “to offer a road map for where countries should invest conservation funding, especially for small nations with limited resources.”

Hashemi started her report by noting that “it’s hard to feel optimistic for coral reefs” these days. It’s hard—if one doesn’t read GNN.

There’s great news on coral all around the world. In terms of protections, 77,000 square miles of tropical seas will be off limits to fishing thanks to bold conservation action by Papua New Guinea this year.

Located in the legendary Coral Triangle, where the Pacific and Indian Oceans meet, the newly-designated Western Manus Marine Protected Area will form part of the newly established Melanesian Ocean Corridor of Reserves, a network of national and jointly managed protected areas spanning Fiji, Vanuatu, and Papua New Guinea.

The science of coral breeding and restoration is advancing in leaps and bounds. This January, GNN reported that scientists on the island nation of Mauritius are naturally breeding heat-resistant corals that faced a bleaching event last summer with 98% survival rates.

Marine biologists weren’t even able to breed coral in a lab 20 years ago, but recently, scientists on the Maldives bred 10,000 corals in just weeks using a portable station shipped in a container to the archipelago.

In 2022, the breeding of coral took a cosmic leap with the first ever out-of-season spawning event for lab-bred corals along Australia’s northeastern coast.Even just learning about these incredible organisms and what they’re capable of is an ongoing and encouraging process. GNN reported in 2024 that a Nat Geo expedition found the world’s largest coral ever, a leviathan shadow on the seabed that stretched out longer than a blue whale—longer than 4 tennis courts. Scientists Have Found Climate-Resistant Coral Reefs Around the World Totaling the Size of Wisconsin
Read More........

World’s first AI‑designed vaccine explained

Neil Mabbott, University of Edinburgh

Researchers at the University of Cambridge have developed what they describe as a fundamentally new type of vaccine using artificial intelligence (AI). The vaccine’s key component was designed entirely by AI and has now been tested in people for the first time.

The goal is ambitious: a single vaccine that works not just against all known human coronavirus variants, but against related bat viruses that could jump from animals to humans and cause future pandemics.

Traditional vaccines train our immune system to recognise one specific virus. The problem is that viruses mutate. When they change enough, the vaccine stops working, which is why we need a new flu shot every year and why COVID vaccines have been updated repeatedly since 2021.

AI offers a way around this. By analysing genetic data from thousands of related viruses, it can identify the parts that stay the same across different strains and that are unlikely to change over time. Target those stable features, and you have a vaccine that should work against the whole family, not just the strain you started with.

This is exactly what the Cambridge team did. They used AI to scan viruses from the sarbecovirus family, which includes the viruses that cause both SARS and COVID, as well as a range of animal coronaviruses – looking for shared features that evolution has left largely untouched. Those features became the basis of the vaccine.

DNA vaccines

While many people are familiar with the mRNA shots used during the pandemic, this new vaccine uses DNA. DNA vaccines are generally more stable than mRNA vaccines, making them easier to store and transport. A significant advantage in lower-income countries where “cold-chain” infrastructure is limited.

They can also be administered without needles. A high-pressure stream of liquid delivers the vaccine through the skin, making administration less painful and easier to scale up during an outbreak.

DNA and RNA viruses explained.

Could it protect against future pandemics?

These practical advantages matter most if the vaccine itself can do something no existing jab can: protect against viruses we haven’t encountered yet.

Broad-spectrum vaccines could change the way the world responds to emerging infectious diseases. By offering much wider protection than traditional vaccines, they could provide rapid immunity against new and emerging viral threats. This would equip public health officials with tools to stop future outbreaks in their tracks before they have a chance to turn into global pandemics.

They could also transform our approach to more familiar diseases. Influenza is a prime target because it exists in many different strains and evolves so rapidly. Scientists have to predict which strains will dominate each flu season, and they guess wrong, vaccine effectiveness can suffer. A universal flu vaccine that targets features shared across multiple strains could eventually end the annual race to keep up with the virus.

And the Ebola virus shows why this matters right now. The recent outbreak in the Democratic Republic of the Congo and Uganda is driven by the Bundibugyo strain, which bypasses existing vaccines. While researchers rush to create a new vaccine specifically for this strain, local communities remain at high risk. A broad-spectrum vaccine designed to cover an entire virus family could transform that picture.

What the trial found

This is the first human trial of an AI-designed vaccine. The results showed that this DNA vaccine was able to stimulate the immune system to produce antibodies that can recognise different types of sarbecoviruses. The technology was found to be safe and well tolerated.

This is an exciting advance because it demonstrates how AI has the potential to design variant-proof vaccines against future pandemic threats. The needle-free delivery system could also make the vaccine easier to administer and distribute worldwide.

However, there is more work to do. Although the results in this study are encouraging, the immune responses following vaccination were modest. It was also uncertain how long the protection lasts and whether further boosters will be required. Larger trials are also needed to determine whether the vaccine can prevent or reduce virus infections in the real world.

A universal vaccine remains a few years away. And any new vaccine must still pass larger trials to prove it is safe, effective and provides lasting protection. But this study shows the goal is getting closer – and AI may help us get there faster.The Conversation

Neil Mabbott, Personal Chair of Immunopathology, University of Edinburgh

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Read More........